Neuren Pharmaceuticals | NEU - Selling And Administration Expenses

Stock Price
11.57
Daily Change
-0.19 -1.62%
Monthly
-9.61%
Yearly
-4.06%
Q1 Forecast
11.51

Neuren Pharmaceuticals reported AUD3.74M in Selling and Administration Expenses for its fiscal semester ending in December of 2025.





Selling And Administration Expenses Change Date
Akebia Therapeutics USD 25.74M 1.93M Mar/2025
Alaunos Therapeutics USD 585K 260K Sep/2025
Avita Medical AUD 19.03M 1.95M Dec/2025
Clinuvel Pharmaceuticals AUD 9.12M 6.2M Jun/2025
Dianthus Therapeutics USD 8.2M 669K Sep/2025
Genetic Signatures AUD 908K 9.61M Dec/2025
Ionis Pharmaceuticals USD 130M 43.43M Dec/2025
Medical Developments International AUD 2.84M 4.19M Dec/2025
Neuren Pharmaceuticals AUD 3.74M 2.5M Dec/2025
Organon & Co USD 399M 54M Sep/2025
Paradigm Biopharmaceuticals AUD 1.61M 747.79K Jun/2025
PYC Therapeutics AUD 328.4K 1.8M Dec/2025
Starpharma Holdings AUD 4.42M 2.86M Dec/2025
Tectonic Therapeutic USD 4.96M 190K Sep/2025
Telix Pharmaceuticals AUD 93.48M 1.04M Dec/2025
Viatris USD 1.03B 144.1M Dec/2025
Xeris Pharmaceuticals USD 46.46M 2.07M Sep/2025